vedolizumab
takeda
['vedo', 'vedolizumab', ' vedo']
impressive data by on earnest. vdz vs placebo for chronic pouchitis. much needed data showing longer term response at wk 34 in pts on vedolizumab with chronic pouchitis. #ecco2023 
Associate Professor, Gastroenterologist - IBD, microbiome, Co-founder https://t.co/Xhgfwnb0dG (digital tool -  management of IBD and bowel preparation)